Stay updated on Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record history now lists revision v3.3.2 and removes v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T16:54:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the general government funding and operating status notice from the page, and the trial record content remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T15:03:48.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Study Status was updated in version 2 on 2021-10-25. Recruitment Status was updated in version 3 on 2023-07-26.
    Difference
    0.1%
    Check dated 2025-11-03T01:30:43.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    13%
    Check dated 2025-10-05T12:47:26.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:37:36.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2 and removed the Back to Top element; no substantive changes to core content, pricing, stock, or time-related information.
    Difference
    0.8%
    Check dated 2025-09-13T23:59:49.000Z thumbnail image

Stay in the know with updates to Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.